Found 1816 clinical trials
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
Additionally, the investigators believe there will be no significant difference in postoperative readmission for pain quality of life at 30 days in either group.
- 0 views
- 06 Jul, 2023
- 1 location
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
Additionally, the investigators believe there will be no significant difference in postoperative readmission for pain quality of life at 30 days in either group.
- 0 views
- 25 Aug, 2023
- 1 location
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
Study details include:The study duration (4-week screening, 24--week intervention, 20--week safety followup) will be 48 weeks.The intervention duration will be 24 weeks.The number of visits will be 7 site visits and 8 phone/remote visits.
- 0 views
- 17 Apr, 2025
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
Study details include:The study duration (4-week screening, 24--week intervention, 20--week safety followup) will be 48 weeks.The intervention duration will be 24 weeks.The number of visits will be 7 site visits and 8 phone/remote visits.
- 0 views
- 17 Apr, 2025
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
Study details include:The study duration (4-week screening, 24--week intervention, 20--week safety followup) will be 48 weeks.The intervention duration will be 24 weeks.The number of visits will be 7 site visits and 8 phone/remote visits.
- 0 views
- 17 Apr, 2025
Families Children and Teachers Thriving Together
Parents will also be invited to participate by completing surveys with NYU study staff. Parents will be consented to complete two surveys when their child is in Pre-K.
- 0 views
- 16 Feb, 2024
- 1 location
A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe Hemophilia (ATLAS-NEO)
The frequency for telephone visits will be approximately every 2 weeks. For site visits the frequency will be approximately every 8 weeks during the SOC period and approximately every 4 weeks during the fitusiran treatment period.
- 0 views
- 24 May, 2024
- 54 locations
Development of a Clinical and Biological Database in Peritoneal Carcinosis (BCB CARCINOSE)
The creation of a prospective clinical-biological base dedicated to peritoneal carcinosis must therefore be able to serve as a support for this essential search for transfer.
- 0 views
- 16 Feb, 2024
- 1 location
Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11)
Once the study objectives have been met or the study has ended, participants will be discontinued from this study and will be enrolled in an extension study to continue protocol-defined assessments and treatment.
- 0 views
- 16 Feb, 2024
- 14 locations
A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475).
- 0 views
- 20 Jul, 2022
- 24 locations